News from Novo Nordisk

Here's how three of the market's biggest decliners can bounce back

Novo Nordisk shares fall 5.4% after latest trial results for its next-generation weight loss drug

Novo Slashes Wegovy Price, Undercutting Its Most Bitter Rival

Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy

Shares of Hims & Hers plunge after bullish outlook on semaglutide

Prediction: These Could Be the Best-Performing Value Stocks Through 2030

Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs

Novo Pops After Ozempic Beats. But Supply Shortages Expected.

No plan to prop up global health, Novo Nordisk Foundation says, as Trump freezes US aid

Ozempic maker Novo Nordisk failed to disclose millions it paid to healthcare groups - watchdog

Novo Nordisk shares pop 9% on early-stage weight loss drug trial results

Novo Nordisk expands AI partnership with Valo Health for development of obesity drugs

Retail investors buy Novo dip after disappointing weight-loss drug data

CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?

In weight loss battle, Novo and Lilly face growing offensive from licensed copies

Tennessee woman accused of selling fake weight loss drugs as counterfeit concerns grow

Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing

The weight-loss drug boom has become one of the internet's biggest scams

Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 million